Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

NCT07681076 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: KarXT
DRUG: Trimethobenzamide
DRUG: Ondansetron
DRUG: Meclizine

Sponsor

Karuna Therapeutics, Inc., a Bristol Myers Squibb company